Adrenomedullin (HuBit Genomix)
N/A
Report date: 2023/10/19 20:00:40
Base Information
Drug NameAdrenomedullin (HuBit Genomix)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHubit GenomixNational Cerebral And Cardiovascular Center
China Registration ClassN/A
Develop Information
Active CompaniesNational Cerebral And Cardiovascular Center
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A